Mona O. Mohsen

3.7k total citations · 4 hit papers
64 papers, 2.6k citations indexed

About

Mona O. Mohsen is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Mona O. Mohsen has authored 64 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 22 papers in Infectious Diseases and 14 papers in Molecular Biology. Recurrent topics in Mona O. Mohsen's work include Immunotherapy and Immune Responses (18 papers), SARS-CoV-2 and COVID-19 Research (15 papers) and COVID-19 Clinical Research Studies (8 papers). Mona O. Mohsen is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), SARS-CoV-2 and COVID-19 Research (15 papers) and COVID-19 Clinical Research Studies (8 papers). Mona O. Mohsen collaborates with scholars based in Switzerland, United Kingdom and Qatar. Mona O. Mohsen's co-authors include Martin F. Bachmann, Monique Vogel, Gustavo Cabral‐Miranda, Lisha Zha, Ariane C. Gomes, Anne‐Cathrine S. Vogt, Tasneem Arsiwala, Daniel E. Speiser, Vania Manolova and Gilles Augusto and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mona O. Mohsen

60 papers receiving 2.5k citations

Hit Papers

Major findings and recent advances in virus–like particle... 2017 2026 2020 2023 2017 2021 2022 2022 100 200 300 400

Peers

Mona O. Mohsen
Julia Y. Wang United States
Robert G. Ulrich United States
Nina M. van Sorge Netherlands
Franco H. Falcone United Kingdom
Manohar R. Furtado United States
Xuguang Li Canada
Gary T. Jennings Switzerland
Julia Y. Wang United States
Mona O. Mohsen
Citations per year, relative to Mona O. Mohsen Mona O. Mohsen (= 1×) peers Julia Y. Wang

Countries citing papers authored by Mona O. Mohsen

Since Specialization
Citations

This map shows the geographic impact of Mona O. Mohsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona O. Mohsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona O. Mohsen more than expected).

Fields of papers citing papers by Mona O. Mohsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona O. Mohsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona O. Mohsen. The network helps show where Mona O. Mohsen may publish in the future.

Co-authorship network of co-authors of Mona O. Mohsen

This figure shows the co-authorship network connecting the top 25 collaborators of Mona O. Mohsen. A scholar is included among the top collaborators of Mona O. Mohsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona O. Mohsen. Mona O. Mohsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bachmann, Martin F., Mona O. Mohsen, & Daniel E. Speiser. (2025). The impact of viral evolution on vaccine development for SARS-CoV-2. Current Opinion in Immunology. 96. 102612–102612.
2.
Mohsen, Mona O., et al.. (2024). Regulation of pulmonary plasma cell responses during secondary infection with influenza virus. The Journal of Experimental Medicine. 221(7). 9 indexed citations
3.
Vogt, Anne‐Cathrine S., Jan M. Sobczak, Albert Osterhaus, et al.. (2024). Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines. 12(8). 874–874. 6 indexed citations
4.
Mohsen, Mona O., et al.. (2024). Childhood asthma biomarkers including zinc: An exploratory cross-sectional study. World Journal of Clinical Pediatrics. 13(1). 87866–87866. 1 indexed citations
5.
Roques, Magali, Anne‐Cathrine S. Vogt, Ina Baļķe, et al.. (2024). Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development. npj Vaccines. 9(1). 225–225. 1 indexed citations
6.
Vogt, Anne‐Cathrine S., Albert Osterhaus, Mona O. Mohsen, et al.. (2024). Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines. Vaccines. 12(9). 1053–1053. 5 indexed citations
7.
Mohsen, Mona O., Daniel E. Speiser, Justine Michaux, et al.. (2022). Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma. Journal for ImmunoTherapy of Cancer. 10(1). e002927–e002927. 24 indexed citations
8.
Vogt, Anne‐Cathrine S., et al.. (2021). Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes. Vaccines. 9(11). 1316–1316. 11 indexed citations
9.
Peterhoff, David, Jan M. Sobczak, Mona O. Mohsen, et al.. (2021). Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery. Vaccines. 9(6). 642–642. 11 indexed citations
10.
Zha, Lisha, Xinyue Chang, Hongxin Zhao, et al.. (2021). Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles. Vaccines. 9(4). 395–395. 36 indexed citations
11.
Chang, Xinyue, Andris Zeltiņš, Mona O. Mohsen, et al.. (2021). A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain. Vaccines. 9(11). 1287–1287. 11 indexed citations
12.
Mohsen, Mona O., Ina Baļķe, B Martina, et al.. (2021). Neutralization of MERS coronavirus through a scalable nanoparticle vaccine. npj Vaccines. 6(1). 107–107. 11 indexed citations
13.
Baļķe, Ina, Andris Zeltiņš, Simone de Brot, et al.. (2021). The impact of size on particle drainage dynamics and antibody response. Journal of Controlled Release. 331. 296–308. 36 indexed citations
14.
Bachmann, Martin F., Mona O. Mohsen, Lisha Zha, Monique Vogel, & Daniel E. Speiser. (2021). SARS-CoV-2 structural features may explain limited neutralizing-antibody responses. npj Vaccines. 6(1). 2–2. 43 indexed citations
15.
Bachmann, Martin F., Mona O. Mohsen, Matthias Krämer, & Matthew D. Heath. (2020). Vaccination against Allergy: A Paradigm Shift?. Trends in Molecular Medicine. 26(4). 357–368. 24 indexed citations
16.
Mohsen, Mona O., Matthew D. Heath, Gustavo Cabral‐Miranda, et al.. (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for ImmunoTherapy of Cancer. 7(1). 114–114. 51 indexed citations
17.
Klimek, Ludger, Thomas M. Kündig, Matthias Krämer, et al.. (2018). Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases. Allergo Journal International. 27(8). 245–255. 37 indexed citations
18.
Zha, Lisha, Lichun He, Weidong Xie, et al.. (2017). Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis. PLoS ONE. 12(5). e0177964–e0177964. 6 indexed citations
19.
Mohsen, Mona O., Ariane C. Gomes, Gustavo Cabral‐Miranda, et al.. (2017). Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination. Journal of Controlled Release. 251. 92–100. 66 indexed citations
20.
Miller, Daniel, et al.. (2016). Calm Vessels: Cultural Expectations of Pregnant Women in Qatar. 11(2). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026